<DOC>
	<DOCNO>NCT03024502</DOCNO>
	<brief_summary>The present study aim evaluate safety two mucoadhesive gel contain propolis standardize extract identify EPP-AF , 1 2 % propolis . The efficacy study propolis gel perform comparison clotrimazole cream patient present vulvovaginal candidiasis .</brief_summary>
	<brief_title>Patients With Vulvovaginal Candidiasis</brief_title>
	<detailed_description>Vaginal candidiasis second infection genital tract bacterial vaginosis . Up 75 % woman least one episode live , clinical manifestation variable . Around 10 20 % asymptomatic 5 10 % recurrent candidiasis mean 4 episode year . The predominant symptom pruritus 89 % burn urination sexual intercourse 66 % . The therapeutic regimen acute fungal infection C. albicans consider intensity clinical symptom , recurrence , patient preference route administration consequent adherence treatment , presence pregnancy possibility side effect . In general , schemes include anti-fungal substance azoles type . Intravaginal administration drug require development formulation suit area adherence treatment increase mucoadhesive formulation obtain avoid discomfort provide adequate release active compound . In sense , present project objective develop mucoadhesive gel contain Propolis Standardized ( EPP-AFÂ® ) treatment vaginal candidiasis , especially since preclinical efficacy safety data demonstrate clinical potential product . So present proposal aim clinical study evaluate efficacy two formulation 1 2 % propolis comparison clotrimazole cream treatment ( patient affect Candidiasis ) also evaluate safety propolis gel healthy volunteer . The efficacy protocol test product patient vaginal candidiasis perform open-label , randomize , three-arm , clinical trial active clotrimazole-based control . Patients recruit ( T0 ) evaluate 10 30 day initiation treatment , primary outcome clinical cure rate .</detailed_description>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Candidiasis , Vulvovaginal</mesh_term>
	<criteria>Have perform clinical laboratory diagnosis vulvovaginitis Candida cPatients recurrent candidiasis ; History hepatic , renal , hematological , cardiovascular disease decompensated diabetes mellitus ( glycemia 200 ) obesity BMI 35 ) ; Diagnosis vulvovaginitis another agent ; Make use chronic antimicrobial ( informed patient ) Be pregnant Allergy component medication give</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>vulvovaginal candidiasis</keyword>
	<keyword>EPPAF mucoadhesive gel</keyword>
	<keyword>clotrimazol</keyword>
</DOC>